T1	tradename 1526 1533	Mircera
T3	tradename 1598 1606	Mircera.
T5	tradename 1608 1615	Mircera
T7	nanoparticle 1617 1658	methoxy polyethylene glycol-epoetin beta)
T9	routeofadministration 1686 1702	Intravenous [IV]
T11	routeofadministration 1706 1723	Subcutaneous [SC]
T13	fdaapprovaldate 1751 1755	2007
T15	adversereaction 1797 1802	DEATH
T17	adversereaction 1804 1825	MYOCARDIAL INFARCTION
T19	adversereaction 1827 1833	STROKE
T21	adversereaction 1835 1857	VENOUS THROMBOEMBOLISM
T23	adversereaction 1859 1888	THROMBOSIS OF VASCULAR ACCESS
T25	adversereaction 1893 1910	TUMOR PROGRESSION
T27	adversereaction 2076 2081	death
T29	adversereaction 2099 2123	cardiovascular reactions
T31	adversereaction 2129 2135	stroke
T33	tradename 2384 2391	Mircera
T35	tradename 2484 2491	Mircera
T37	tradename 2613 2620	Mircera
T39	adversereaction 2658 2664	deaths
T41	tradename 2690 2697	Mircera
T43	adversereaction 2785 2802	tumor progression
T45	tradename 3299 3306	Mircera
T47	indication 3383 3428	anemia associated with chronic kidney disease
T49	tradename 3522 3529	Mircera
T51	tradename 3745 3752	Mircera
T53	tradename 3865 3872	Mircera
T55	routeofadministration 3892 3909	subcutaneous (SC)
T57	routeofadministration 3913 3929	intravenous (IV)
T59	dose 3969 3979	0.6 mcg/kg
T61	frequency 4005 4025	once every two weeks
T63	frequency 4070 4082	once monthly
T65	frequency 4086 4106	once every two weeks
T67	tradename 4298 4305	Mircera
T69	adversereaction 4403 4431	Pure red cell aplasia (PRCA)
T71	tradename 4465 4472	Mircera
T73	adversereaction 4528 4554	serious allergic reactions
T75	tradename 4558 4565	Mircera
T77	adversereaction 4577 4588	anaphylaxis
T79	adversereaction 4625 4644	Increased Mortality
T81	adversereaction 4646 4667	Myocardial Infarction
T83	adversereaction 4669 4675	Stroke
T85	adversereaction 4683 4699	Thromboembolism:
T87	tradename 5064 5071	Mircera
T89	adversereaction 5081 5099	Seizures: Seizures
T91	tradename 5147 5154	Mircera
T93	adversereaction 5278 5283	PRCA:
T95	adversereaction 5287 5300	severe anemia
T97	adversereaction 5305 5327	low reticulocyte count
T99	tradename 5343 5350	Mircera
T101	tradename 5371 5378	Mircera
T103	adversereaction 5396 5400	PRCA
T105	adversereaction 5487 5499	hypertension
T107	adversereaction 5501 5509	diarrhea
T109	adversereaction 5511 5527	nasopharyngitis.
T111	adversereaction 5799 5804	DEATH
T113	adversereaction 5806 5827	MYOCARDIAL INFARCTION
T115	adversereaction 5829 5835	STROKE
T117	adversereaction 5837 5859	VENOUS THROMBOEMBOLISM
T119	adversereaction 5861 5890	THROMBOSIS OF VASCULAR ACCESS
T121	adversereaction 5896 5913	TUMOR PROGRESSION
T123	indication 5961 5997	Anemia Due to Chronic Kidney Disease
T125	tradename 6192 6199	Mircera
T127	adversereaction 6288 6307	Increased Mortality
T129	adversereaction 6309 6330	Myocardial Infarction
T131	adversereaction 6332 6338	Stroke
T133	adversereaction 6344 6359	Thromboembolism
T135	adversereaction 6366 6385	Increased Mortality
T137	adversereaction 6411 6428	Tumor Progression
T139	adversereaction 6491 6499	Seizures
T141	tradename 6545 6552	Mircera
T143	tradename 6554 6555	5
T145	adversereaction 6558 6579	Pure Red Cell Aplasia
T147	adversereaction 6581 6582	5
T149	adversereaction 6585 6611	Serious Allergic Reactions
T151	adversereaction 7439 7444	DEATH
T153	adversereaction 7446 7467	MYOCARDIAL INFARCTION
T155	adversereaction 7469 7475	STROKE
T157	adversereaction 7477 7499	VENOUS THROMBOEMBOLISM
T159	adversereaction 7501 7530	THROMBOSIS OF VASCULAR ACCESS
T161	adversereaction 7537 7554	TUMOR PROGRESSION
T163	adversereaction 7694 7699	death
T165	adversereaction 7717 7741	cardiovascular reactions
T167	adversereaction 7747 7753	stroke
T169	tradename 8002 8009	Mircera
T171	tradename 8133 8140	Mircera
T173	tradename 8262 8269	Mircera
T175	adversereaction 8307 8313	deaths
T177	tradename 8339 8346	Mircera
T179	adversereaction 8438 8455	tumor progression
T181	indication 8618 8654	Anemia Due to Chronic Kidney Disease
T183	tradename 8657 8664	Mircera
T185	indication 8699 8750	anemia associated with chronic kidney disease (CKD)
T187	tradename 8838 8845	Mircera
T189	tradename 9115 9122	Mircera
T191	tradename 9560 9567	Mircera
T193	tradename 9700 9707	Mircera
T195	adversereaction 9862 9867	death
T197	adversereaction 9885 9909	cardiovascular reactions
T199	adversereaction 9915 9921	stroke
T201	adversereaction 10270 10275	death
T203	frequency 10765 10784	once every 4 weeks.
T205	tradename 10964 10971	Mircera
T207	tradename 11270 11277	Mircera
T209	tradename 11505 11512	Mircera
T211	tradename 11551 11558	Mircera
T213	routeofadministration 11582 11600	intravenously (IV)
T215	routeofadministration 11604 11624	subcutaneously (SC).
T217	routeofadministration 11644 11646	SC
T219	tradename 11648 11655	Mircera
T221	tradename 11753 11760	Mircera
T223	tradename 11907 11915	Mircera.
T225	tradename 11950 11957	Mircera
T227	indication 11979 11998	anemia in adult CKD
T229	dose 12053 12063	0.6 mcg/kg
T231	routeofadministration 12101 12103	IV
T233	routeofadministration 12107 12109	SC
T235	frequency 12120 12141	once every two weeks.
T237	routeofadministration 12147 12149	IV
T239	routeofadministration 12219 12221	IV
T241	tradename 12327 12334	Mircera
T243	frequency 12355 12367	once monthly
T245	frequency 12407 12421	every-two-week
T247	tradename 12530 12537	Mircera
T249	tradename 12899 12906	Mircera
T251	tradename 12935 12942	Mircera
T253	tradename 13029 13036	Mircera
T255	indication 13058 13077	anemia in adult CKD
T257	dose 13132 13142	0.6 mcg/kg
T259	routeofadministration 13180 13182	IV
T261	routeofadministration 13186 13188	SC
T263	frequency 13204 13220	every two weeks.
T265	tradename 13264 13271	Mircera
T267	frequency 13292 13304	once monthly
T269	frequency 13344 13358	every-two-week
T271	tradename 13440 13447	Mircera
T273	tradename 13574 13581	Mircera
T275	tradename 13603 13610	Mircera
T277	frequency 13631 13651	once every two weeks
T279	frequency 13655 13667	once monthly
T281	tradename 13770 13777	Mircera
T283	routeofadministration 13797 13799	IV
T285	routeofadministration 13803 13805	SC
T287	tradename 13900 13907	Mircera
T289	frequency 14007 14013	/week)
T291	frequency 14060 14066	/week)
T293	tradename 14069 14076	Mircera
T295	frequency 14084 14096	Once Monthly
T297	frequency 14101 14129	/month) Once Every Two Weeks
T299	frequency 14135 14151	every two weeks)
T301	tradename 14281 14288	Mircera
T303	tradename 14291 14298	Mircera
T305	tradename 14347 14354	Mircera
T307	tradename 14538 14545	Mircera
T309	tradename 14672 14679	Mircera
T311	tradename 15370 15378	Mircera.
T313	tradename 15448 15455	Mircera
T315	tradename 15569 15576	Mircera
T317	tradename 15657 15664	Mircera
T319	adversereaction 15769 15797	Pure red cell aplasia (PRCA)
T321	tradename 15831 15838	Mircera
T323	adversereaction 15938 15963	severe allergic reactions
T325	tradename 15967 15974	Mircera
T327	adversereaction 15981 16003	anaphylactic reactions
T329	adversereaction 16005 16015	angioedema
T331	adversereaction 16017 16029	bronchospasm
T333	adversereaction 16031 16040	skin rash
T335	adversereaction 16046 16056	urticaria)
T337	adversereaction 16096 16115	Increased Mortality
T339	adversereaction 16117 16138	Myocardial Infarction
T341	adversereaction 16140 16146	Stroke
T343	adversereaction 16152 16167	Thromboembolism
T345	adversereaction 16333 16338	death
T347	adversereaction 16340 16361	myocardial infarction
T349	adversereaction 16363 16369	stroke
T351	adversereaction 16371 16395	congestive heart failure
T353	adversereaction 16397 16439	thrombosis of hemodialysis vascular access
T355	adversereaction 16451 16472	thromboembolic events
T357	adversereaction 16607 16631	cardiovascular reactions
T359	adversereaction 16934 16958	cardiovascular reactions
T361	adversereaction 16963 16972	mortality
T363	adversereaction 17174 17179	death
T365	adversereaction 17200 17225	cardiovascular reactions.
T367	adversereaction 17259 17280	myocardial infarction
T369	adversereaction 17285 17292	stroke.
T371	adversereaction 17352 17357	death
T373	adversereaction 17441 17469	deep venous thrombosis (DVT)
T375	indication 20206 20223	anemia due to CKD
T377	tradename 23547 23554	Mircera
T379	adversereaction 24811 24830	Increased Mortality
T381	adversereaction 24856 24873	Tumor Progression
T383	tradename 24914 24921	Mircera
T385	tradename 25050 25057	Mircera
T387	tradename 25219 25226	Mircera
T389	activeingredient 31198 31210	epoetin beta
T391	activeingredient 31416 31428	epoetin beta
T393	activeingredient 31495 31507	epoetin beta
T395	activeingredient 31597 31609	epoetin beta
T397	tradename 32222 32229	Mircera
T399	tradename 32298 32305	Mircera
T401	adversereaction 32480 32507	Hypertensive encephalopathy
T403	adversereaction 32516 32524	seizures
T405	tradename 32578 32585	Mircera
T407	tradename 32710 32718	Mircera.
T409	tradename 32741 32748	Mircera
T411	adversereaction 32953 32961	Seizures
T413	adversereaction 32964 32972	Seizures
T415	tradename 33016 33023	Mircera
T417	tradename 33100 33107	Mircera
T419	tradename 33355 33362	Mircera
T421	tradename 33408 33415	Mircera
T423	adversereaction 33603 33607	PRCA
T425	adversereaction 33666 33670	PRCA
T427	tradename 33762 33769	Mircera
T429	adversereaction 33825 33846	Pure Red Cell Aplasia
T431	adversereaction 33858 33862	PRCA
T433	adversereaction 33870 33883	severe anemia
T435	adversereaction 33907 33917	cytopenias
T437	tradename 34073 34081	Mircera.
T439	routeofadministration 34159 34161	SC
T441	adversereaction 34180 34184	PRCA
T443	tradename 34225 34233	Mircera.
T445	adversereaction 34236 34240	PRCA
T447	tradename 34360 34367	Mircera
T449	adversereaction 34392 34405	severe anemia
T451	adversereaction 34410 34432	low reticulocyte count
T453	tradename 34463 34470	Mircera
T455	tradename 34481 34488	Mircera
T457	tradename 34666 34673	Mircera
T459	tradename 34717 34724	Mircera
T461	company 34751 34756	Roche
T463	tradename 34859 34866	Mircera
T465	adversereaction 34891 34895	PRCA
T467	tradename 34921 34928	Mircera
T469	adversereaction 35077 35103	Serious Allergic Reactions
T471	adversereaction 35106 35132	Serious allergic reactions
T473	adversereaction 35144 35166	anaphylactic reactions
T475	adversereaction 35168 35178	angioedema
T477	adversereaction 35180 35192	bronchospasm
T479	adversereaction 35194 35205	tachycardia
T481	adversereaction 35207 35225	pruritus skin rash
T483	adversereaction 35231 35240	urticaria
T485	tradename 35285 35293	Mircera.
T487	tradename 35356 35363	Mircera
T489	tradename 35405 35412	Mircera
T491	tradename 35492 35499	Mircera
T493	tradename 35699 35707	Mircera.
T495	tradename 35729 35736	Mircera
T497	tradename 35960 35967	Mircera
T499	adversereaction 36709 36728	Increased Mortality
T501	adversereaction 36730 36751	Myocardial Infarction
T503	adversereaction 36753 36759	Stroke
T505	adversereaction 36765 36780	Thromboembolism
T507	adversereaction 36820 36839	Increased mortality
T509	adversereaction 36847 36864	tumor progression
T511	adversereaction 36929 36941	Hypertension
T513	adversereaction 36981 36989	Seizures
T515	adversereaction 37029 37050	Pure red cell aplasia
T517	adversereaction 37090 37116	Serious allergic reactions
T519	adversereaction 37236 37248	hypertension
T521	adversereaction 37287 37295	diarrhea
T523	adversereaction 37301 37317	nasopharyngitis.
T525	tradename 37398 37405	Mircera
T527	adversereaction 37429 37441	hypertension
T529	adversereaction 37443 37466	coronary artery disease
T531	adversereaction 37468 37474	anemia
T533	adversereaction 37525 37538	septic shock.
T535	tradename 37622 37629	Mircera
T537	tradename 37729 37736	Mircera
T539	tradename 37809 37816	Mircera
T541	tradename 38173 38180	Mircera
T543	frequency 38206 38234	once every two or four weeks
T545	routeofadministration 38249 38251	SC
T547	routeofadministration 38255 38258	IV.
T549	tradename 38392 38399	Mircera
T551	tradename 38686 38693	Mircera
T553	tradename 38781 38788	Mircera
T555	tradename 38903 38911	Mircera.
T557	tradename 39028 39035	Mircera
T559	adversereaction 39058 39082	Hypertension Hypotension
T561	adversereaction 39116 39146	Diarrhea Vomiting Constipation
T563	adversereaction 39194 39267	Nasopharyngitis Upper Respiratory Tract Infection Urinary Tract Infection
T565	adversereaction 39302 39310	Headache
T567	adversereaction 39361 39402	Muscle Spasms Back Pain Pain in Extremity
T569	adversereaction 39467 39562	Procedural Hypotension Arteriovenous Fistula Thrombosis Arteriovenous Fistula Site Complication
T571	adversereaction 39605 39619	Fluid Overload
T573	adversereaction 39670 39675	Cough
T575	tradename 39805 39812	Mircera
T577	tradename 40029 40036	Mircera
T579	tradename 40196 40203	Mircera
T581	tradename 40492 40500	Mircera.
T583	tradename 40533 40540	Mircera
T585	tradename 41180 41187	Mircera
T587	tradename 41487 41494	Mircera
T589	nanoparticle 41620 41660	methoxy polyethylene glycol-epoetin beta
T591	routeofadministration 41678 41692	subcutaneously
T593	dose 41781 41790	50 mcg/kg
T595	frequency 41791 41813	once every three days.
T597	dose 42192 42200	5 mcg/kg
T599	frequency 42201 42222	once every three days
T601	nanoparticle 42235 42275	methoxy polyethylene glycol-epoetin beta
T603	frequency 42329 42346	Once-weekly doses
T605	nanoparticle 42350 42390	methoxy polyethylene glycol-epoetin beta
T607	dose 42397 42407	50 mcg/kg/
T609	tradename 42875 42882	Mircera
T611	nanoparticle 42941 42981	methoxy polyethylene glycol-epoetin beta
T613	tradename 43096 43103	Mircera
T615	tradename 43190 43197	Mircera
T617	tradename 43290 43297	Mircera
T619	tradename 44010 44017	Mircera
T621	tradename 44177 44184	Mircera
T623	tradename 44312 44319	Mircera
T625	adversereaction 44423 44435	hypertension
T627	tradename 44544 44551	Mircera
T629	nanoparticle 44553 44593	methoxy polyethylene glycol-epoetin beta
T631	surfacecoating 44813 44846	methoxy polyethylene glycol (PEG)
T633	molecularweight 44876 44878	30
T635	molecularweight 44879 44891	000 daltons)
T637	molecularweight 44952 44954	60
T639	molecularweight 44955 44967	000 daltons.
T641	tradename 44968 44975	Mircera
T643	routeofadministration 45043 45054	intravenous
T645	routeofadministration 45058 45070	subcutaneous
T647	tradename 45114 45121	Mircera
T649	inactiveingredient 45193 45209	sodium phosphate
T651	inactiveingredient 45211 45226	sodium sulphate
T653	inactiveingredient 45228 45236	mannitol
T655	inactiveingredient 45238 45248	methionine
T657	inactiveingredient 45253 45267	poloxamer 188.
T659	tradename 45403 45410	Mircera
T661	tradename 46008 46015	Mircera
T663	tradename 46272 46279	Mircera
T665	indication 46296 46320	anemic patients with CKD
T667	tradename 46381 46388	Mircera
T669	routeofadministration 46515 46517	IV
T671	tradename 46536 46543	Mircera
T673	dose 46544 46554	0.4 mcg/kg
T675	plasmahalflife 46650 46664	134 - 65 hours
T677	clearance 46713 46740	427 0.49 0.18 mL/hr/kg.
T679	routeofadministration 46755 46757	SC
T681	tradename 46776 46783	Mircera
T683	dose 46784 46794	0.8 mcg/kg
T685	plasmahalflife 46869 46884	139 - 67 hours.
T687	tradename 46922 46929	Mircera
T689	tmax 46944 46952	72 hours
T691	routeofadministration 46982 46984	SC
T693	tradename 47034 47041	Mircera
T695	routeofadministration 47052 47054	SC
T697	tradename 47116 47123	Mircera
T699	tradename 47320 47328	Mircera.
T701	tradename 47384 47391	Mircera
T703	frequency 47436 47453	every four weeks.
T705	tradename 47470 47477	Mircera
T707	frequency 47495 47508	every 2 weeks
T709	tradename 47606 47613	Mircera
T711	tradename 47766 47773	Mircera
T713	routeofadministration 47905 47907	SC
T715	tradename 48025 48032	Mircera
T717	tradename 48217 48225	Mircera.
T719	nanoparticle 48227 48268	Methoxy polyethylene glycol- epoetin beta
T721	nanoparticle 48518 48558	methoxy polyethylene glycol-epoetin beta
T723	nanoparticle 48617 48657	methoxy polyethylene glycol-epoetin beta
T725	routeofadministration 48675 48689	subcutaneously
T727	tradename 50564 50571	Mircera
T729	tradename 51458 51465	Mircera
T731	tradename 51564 51571	Mircera
T733	indication 51616 51640	anemic patients with CKD
T735	indication 51769 51783	anemia of CKD.
T737	tradename 52357 52364	Mircera
T739	tradename 52532 52539	Mircera
T741	tradename 52611 52618	Mircera
T743	dose 52623 52633	0.6 mcg/kg
T745	routeofadministration 52647 52649	SC
T747	frequency 52650 52674	once every two 495 weeks
T749	dose 52721 52732	0.45 mcg/kg
T751	routeofadministration 52746 52748	SC
T753	frequency 52749 52761	once a week.
T755	tradename 52834 52841	Mircera
T757	activeingredient 52874 52887	epoetin beta)
T759	tradename 52938 52945	Mircera
T761	dose 52950 52960	0.4 mcg/kg
T763	routeofadministration 52974 52976	IV
T765	frequency 52977 52997	once every two weeks
T767	routeofadministration 53055 53057	IV
T769	frequency 53058 53076	three times a week
T771	tradename 53175 53182	Mircera
T773	frequency 53183 53203	once every two weeks
T775	dose 53260 53271	0.6 mcg/kg.
T777	tradename 53517 53524	Mircera
T779	tradename 53610 53617	Mircera
T781	activeingredient 53647 53664	Epoetin alfa/beta
T783	tradename 53958 53965	Mircera
T785	tradename 54092 54099	Mircera
T787	frequency 54123 54143	once every two weeks
T789	frequency 54147 54168	once every four weeks
T791	tradename 54235 54242	Mircera
T793	tradename 54348 54355	Mircera
T795	frequency 54357 54377	once every two weeks
T797	frequency 54382 54403	once every four weeks
T799	tradename 54713 54720	Mircera
T801	routeofadministration 54721 54723	IV
T803	frequency 54724 54737	every 2 weeks
T805	tradename 54774 54781	Mircera
T807	routeofadministration 54782 54784	IV
T809	frequency 54785 54798	every 4 weeks
T811	activeingredient 54835 54852	Epoetin alfa/beta
T813	routeofadministration 54853 54855	IV
T815	tradename 54891 54898	Mircera
T817	frequency 54902 54915	every 2 weeks
T819	tradename 54952 54959	Mircera
T821	routeofadministration 54960 54962	SC
T823	frequency 54963 54976	every 4 weeks
T825	activeingredient 55013 55025	Epoetin beta
T827	routeofadministration 55026 55028	SC
T829	tradename 55063 55070	Mircera
T831	routeofadministration 55071 55073	IV
T833	frequency 55074 55087	every 2 weeks
T835	routeofadministration 55141 55143	IV
T837	tradename 55179 55186	Mircera
T839	routeofadministration 55187 55192	IV/SC
T841	frequency 55193 55206	every 2 weeks
T843	routeofadministration 55258 55263	IV/SC
T845	tradename 55304 55311	Mircera
T847	tradename 55432 55439	Mircera
T849	tradename 55609 55616	Mircera
T851	tradename 55979 55986	Mircera
T853	tradename 56537 56544	Mircera
T855	tradename 56904 56912	Mircera.
T857	tradename 57063 57070	Mircera
T859	tradename 57112 57119	Mircera
T861	adversereaction 57151 57160	mortality
T863	adversereaction 57170 57194	cardiovascular reactions
T865	adversereaction 57196 57220	thromboembolic reactions
T867	adversereaction 57222 57228	stroke
T869	adversereaction 57235 57252	tumor progression
T871	tradename 57537 57544	Mircera
T873	tradename 57761 57768	Mircera
T875	tradename 57888 57895	Mircera
T877	tradename 57946 57953	Mircera
T879	tradename 58116 58123	Mircera
T881	tradename 58322 58329	MIRCERA
T883	nanoparticle 58345 58386	methoxy polyethylene glycol-epoetin beta)
T885	tradename 58435 58443	Mircera.
T887	tradename 58527 58535	Mircera.
T889	tradename 58601 58608	Mircera
T891	tradename 58892 58899	Mircera
T893	tradename 58942 58950	Mircera.
T895	tradename 59011 59019	Mircera?
T897	tradename 59021 59028	Mircera
T899	tradename 59119 59126	Mircera
T901	tradename 59289 59297	Mircera.
T903	tradename 59419 59426	Mircera
T905	tradename 59581 59589	Mircera.
T907	tradename 59611 59618	Mircera
T909	tradename 60655 60663	Mircera?
T911	tradename 60717 60724	Mircera
T913	tradename 60789 60796	Mircera
T915	tradename 60889 60897	Mircera?
T917	tradename 60900 60907	Mircera
T919	tradename 61024 61031	Mircera
T921	tradename 61118 61125	Mircera
T923	tradename 61186 61193	Mircera
T925	tradename 61507 61514	Mircera
T927	tradename 61579 61586	Mircera
T929	tradename 61746 61753	Mircera
T931	tradename 61851 61858	Mircera
T933	tradename 61923 61931	Mircera?
T935	tradename 61946 61953	Mircera
T937	tradename 62207 62214	Mircera
T939	tradename 62299 62306	Mircera
T941	tradename 62365 62373	Mircera?
T943	tradename 62375 62382	Mircera
T945	tradename 62723 62730	Mircera
T947	tradename 62821 62828	Mircera
T949	tradename 63188 63196	Mircera?
T951	tradename 63249 63256	Mircera
T953	tradename 63375 63383	Mircera.
T955	tradename 63392 63399	Mircera
T957	tradename 63478 63485	Mircera
T959	tradename 63582 63589	Mircera
T961	tradename 63766 63773	Mircera
T963	tradename 63872 63879	Mircera
T965	tradename 64134 64142	Mircera?
T967	tradename 64145 64152	Mircera
T969	tradename 64252 64260	Mircera?
T971	tradename 64333 64340	Mircera
T973	tradename 64483 64491	Mircera.
T975	adversereaction 64756 64765	Seizures.
T977	adversereaction 64784 64792	seizures
T979	tradename 64806 64813	Mircera
T981	tradename 64936 64944	Mircera.
T983	tradename 65105 65112	Mircera
T985	tradename 65173 65181	Mircera.
T987	tradename 65217 65225	Mircera.
T989	adversereaction 65339 65346	anemia.
T991	tradename 65478 65486	Mircera.
T993	adversereaction 65491 65517	Serious allergic reaction.
T995	adversereaction 65519 65545	Serious allergic reactions
T997	adversereaction 65558 65562	rash
T999	adversereaction 65586 65605	shortness of breath
T1001	adversereaction 65607 65615	wheezing
T1003	adversereaction 65617 65626	dizziness
T1005	adversereaction 65631 65639	fainting
T1007	adversereaction 65677 65685	swelling
T1009	adversereaction 65713 65723	fast pulse
T1011	adversereaction 65728 65737	sweating.
T1013	adversereaction 65753 65778	serious allergic reaction
T1015	tradename 65791 65798	Mircera
T1017	tradename 65901 65908	Mircera
T1019	adversereaction 65920 65928	Diarrhea
T1021	adversereaction 65932 65966	Upper respiratory tract infections
T1023	tradename 66158 66166	Mircera.
T1025	tradename 66461 66469	Mircera?
T1027	tradename 66478 66485	Mircera
T1029	tradename 66590 66597	Mircera
T1031	tradename 66704 66712	Mircera.
T1033	tradename 66725 66732	Mircera
T1035	tradename 66790 66797	Mircera
T1037	tradename 66835 66842	Mircera
T1039	tradename 66869 66877	Mircera.
T1041	tradename 66885 66892	Mircera
T1043	tradename 66968 66975	Mircera
T1045	tradename 67083 67090	Mircera
T1047	tradename 67153 67160	Mircera
T1049	tradename 67321 67329	Mircera.
T1051	tradename 67372 67379	Mircera
T1053	tradename 67491 67498	Mircera
T1055	tradename 67572 67580	Mircera?
T1057	nanoparticle 67602 67642	methoxy polyethylene glycol-epoetin beta
T1059	inactiveingredient 67667 67683	sodium phosphate
T1061	inactiveingredient 67685 67700	sodium sulphate
T1063	inactiveingredient 67702 67710	mannitol
T1065	inactiveingredient 67712 67722	methionine
T1067	inactiveingredient 67727 67736	poloxamer
T1069	company 67826 67848	Hoffmann-La Roche Inc.
T1071	company 67853 67866	Genentech USA
T1073	company 67891 67902	Roche Group
T1075	company 68019 68041	Hoffmann-La Roche Inc.
